403
Sorry!!
Error! We're sorry, but the page you were looking for doesn't exist.
Afghanistan boosts its domestic pharmaceutical production
(MENAFN) Afghanistan has boosted its domestic pharmaceutical production, now generating a total of 2,356 medical products through 63 active facilities, according to an announcement by the acting deputy prime minister for economic affairs.
The statement noted, "Currently, 63 pharmaceutical manufacturing factories are operating across the country. These factories produce 2,356 different pharmaceutical items."
These locally produced medicines now fulfill roughly 10 to 15 percent of Afghanistan’s overall pharmaceutical demand. The statement also emphasized that the quality of these domestically manufactured drugs is regarded as high.
The interim government has urged both national and international investors to support sectors such as healthcare and mining, highlighting the potential of such investments to ease economic pressures and open up employment opportunities across the country.
The statement noted, "Currently, 63 pharmaceutical manufacturing factories are operating across the country. These factories produce 2,356 different pharmaceutical items."
These locally produced medicines now fulfill roughly 10 to 15 percent of Afghanistan’s overall pharmaceutical demand. The statement also emphasized that the quality of these domestically manufactured drugs is regarded as high.
The interim government has urged both national and international investors to support sectors such as healthcare and mining, highlighting the potential of such investments to ease economic pressures and open up employment opportunities across the country.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.

Comments
No comment